Sagimet Biosciences (SGMT) Stock Chart & Stock Price History → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free SGMT Stock Alerts $5.33 -0.07 (-1.30%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Sagimet Biosciences Stock Price Performance5 Day Performance+10.58%1 Month Performance+29.68%3 Month Performance-11.46%6 Month Performance+40.63%Year-To-Date Performance-1.66% Receive SGMT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsOn June 10, Nvidia makes its next big moveA small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. SGMT Stock Chart for Saturday, June, 1, 2024 SGMT Chart by TradingView Sagimet Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$5.40$5.33-1.30%$5.60$5.16472,590 shs$161.98 million05/30/2024$5.47$5.40-1.28%$5.70$5.25943,477 shs$164.11 million05/29/2024$5.17$5.47+5.80%$5.52$5.02761,315 shs$166.25 million05/28/2024$4.82$5.17+7.26%$5.25$4.90777,807 shs$157.12 million05/27/2024$4.82$4.82$4.91$4.60319,000 shs$146.48 million05/24/2024$4.70$4.82+2.55%$4.91$4.60319,080 shs$153.83 million Get the Latest News and Ratings for SGMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$5.08$4.70-7.48%$5.14$4.64435,162 shs$149.98 million05/22/2024$4.79$5.08+6.05%$5.20$4.66588,516 shs$162.10 million05/21/2024$4.74$4.79+1.05%$4.83$4.44739,055 shs$152.85 million05/20/2024$4.62$4.74+2.60%$5.03$4.54814,619 shs$151.25 million05/17/2024$4.75$4.62-2.74%$4.76$4.54269,303 shs$147.42 million05/16/2024$4.62$4.75+2.81%$4.95$4.68305,914 shs$151.57 million05/15/2024$4.38$4.62+5.48%$4.84$4.41409,429 shs$147.42 million05/14/2024$4.24$4.38+3.30%$4.56$4.31320,805 shs$135.32 million05/13/2024$4.44$4.24-4.50%$4.59$4.24338,711 shs$135.30 million05/10/2024$4.57$4.44-2.84%$4.72$4.36373,985 shs$141.70 million05/09/2024$4.44$4.57+2.93%$4.60$4.33395,872 shs$145.85 million05/08/2024$4.33$4.44+2.54%$4.44$4.04312,812 shs$141.68 million05/07/2024$4.28$4.33+1.17%$4.40$4.16288,054 shs$138.17 million05/06/2024$4.32$4.28-0.93%$4.56$4.16559,221 shs$136.58 million05/03/2024$4.45$4.32-2.92%$4.76$4.25770,646 shs$137.85 million05/02/2024$4.11$4.45+8.27%$4.95$4.251.13 million shs$142 million05/01/2024$3.90$4.11+5.38%$4.28$3.94308,884 shs$131.15 million04/30/2024$4.23$3.90-7.80%$4.22$3.90598,993 shs$124.45 million04/29/2024$4.06$4.23+4.19%$4.29$4.05475,474 shs$135.00 million04/26/2024$3.92$4.06+3.57%$4.15$3.88325,271 shs$129.56 million04/25/2024$4.17$3.92-6.00%$4.08$3.91225,060 shs$125.10 million04/24/2024$4.28$4.17-2.57%$4.27$4.02219,072 shs$133.07 million04/23/2024$4.03$4.28+6.20%$4.31$4.01360,993 shs$136.58 million04/22/2024$4.01$4.03+0.50%$4.18$3.96303,611 shs$128.60 million04/19/2024$3.97$4.01+1.01%$4.07$3.83430,096 shs$127.96 million04/18/2024$4.07$3.97-2.46%$4.17$3.93337,339 shs$126.68 million04/17/2024$4.18$4.07-2.63%$4.36$4.05315,657 shs$129.87 million04/16/2024$4.56$4.18-8.33%$4.50$4.15430,611 shs$133.38 million04/15/2024$4.83$4.56-5.59%$4.88$4.50470,542 shs$145.53 million04/12/2024$5.22$4.83-7.47%$5.17$4.80433,715 shs$154.13 million04/11/2024$5.06$5.22+3.16%$5.30$4.95256,409 shs$166.59 million04/10/2024$5.31$5.06-4.71%$5.15$4.90488,800 shs$161.47 million04/09/2024$5.38$5.31-1.30%$5.53$5.02561,876 shs$169.44 million04/08/2024$5.31$5.38+1.32%$5.56$5.28472,117 shs$171.68 millionTrump’s arrest is phase one (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now.04/05/2024$5.45$5.31-2.57%$5.50$5.29268,300 shs$169.44 million04/04/2024$5.43$5.45+0.37%$5.69$5.24748,389 shs$173.91 million04/03/2024$5.24$5.43+3.63%$5.55$5.11521,252 shs$173.27 million04/02/2024$5.23$5.24+0.19%$5.30$4.88585,542 shs$167.21 million04/01/2024$5.42$5.23-3.51%$5.83$5.21776,763 shs$111.79 million03/29/2024$5.42$5.42$6.05$5.351.15 million shs$115.88 million03/28/2024$5.73$5.42-5.41%$6.05$5.351.15 million shs$115.88 million03/27/2024$5.23$5.73+9.56%$6.06$5.001.26 million shs$122.51 million03/26/2024$5.22$5.23+0.19%$5.67$5.001.32 million shs$111.79 million03/25/2024$4.51$5.22+15.74%$5.70$4.753.24 million shs$111.60 million03/22/2024$4.65$4.51-3.01%$4.69$4.44474,614 shs$96.42 million03/21/2024$4.56$4.65+1.97%$4.98$4.51866,170 shs$99.39 million03/20/2024$4.48$4.56+1.79%$4.58$4.30453,453 shs$97.49 million03/19/2024$4.02$4.48+11.44%$4.72$4.031.44 million shs$95.78 million03/18/2024$4.04$4.02-0.50%$4.24$3.85637,037 shs$85.95 million03/15/2024$4.32$4.04-6.48%$4.58$3.973.86 million shs$86.38 million03/14/2024$4.65$4.32-7.10%$4.73$4.261.79 million shs$92.36 million03/13/2024$4.99$4.65-6.81%$5.26$4.521.31 million shs$99.42 million03/12/2024$5.48$4.99-8.94%$5.57$4.971.04 million shs$106.66 million03/11/2024$5.75$5.48-4.70%$5.94$5.46491,429 shs$117.16 million03/08/2024$6.45$5.75-10.85%$6.76$5.75595,974 shs$122.94 million03/07/2024$6.67$6.45-3.30%$7.41$6.35775,732 shs$137.87 million03/06/2024$6.05$6.67+10.25%$6.70$6.07602,738 shs$142.61 million03/05/2024$6.25$6.05-3.20%$6.34$5.61696,238 shs$129.35 million03/04/2024$6.02$6.25+3.82%$6.45$5.75830,932 shs$133.63 million03/01/2024$6.13$6.02-1.79%$6.65$5.85742,817 shs$128.71 million02/29/2024$6.39$6.13-4.07%$6.83$5.90796,034 shs$131.06 million Related Companies: CytomX Therapeutics Stock Chart Context Therapeutics Stock Chart ProQR Therapeutics Stock Chart Gossamer Bio Stock Chart RAPT Therapeutics Stock Chart Alimera Sciences Stock Chart Syros Pharmaceuticals Stock Chart InterCure Stock Chart Cybin Stock Chart Rigel Pharmaceuticals Stock Chart Receive SGMT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SGMT) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.